Yue Na, Ye Ming, Zhang Ran, Wang Miao
Department of Pathology, The Third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Urumqi, Xinjiang Uygur Autonomous Region 830011, P.R. China.
Department of Pathology, Occupational Disease Hospital, Urumqi, Xinjiang Uygur Autonomous Region 830091, P.R. China.
Exp Ther Med. 2020 Aug;20(2):1746-1751. doi: 10.3892/etm.2020.8814. Epub 2020 May 28.
The aim of the present study was to explore the roles of microRNA-1307-3p (miR-1307-3p) in colorectal cancer (CRC). Firstly, the expression level of miR-1307-3p in CRC cells was measured using reverse transcription-quantitative PCR. Subsequently, Cell Counting Kit-8 and Transwell invasion assays were performed to evaluate the effects of miR-1307-3p on CRC cell proliferation and invasion, respectively. Bioinformatics tools and dual luciferase reporter assays were used to validate the targets of miR-1307-3p. Rescue experiments were performed to confirm tumor suppressor candidate 5 (TUSC5) as a functional target of miR-1307-3p. miR-1307-3p levels were revealed to be upregulated in CRC cells when compared with the normal human epithelial cell line. Knockdown of miR-1307-3p inhibited CRC cell growth and invasiveness. Bioinformatics analysis and dual-luciferase activity reporter assays demonstrated that miR-1307-3p binds the 3'-untranslated region of TUSC5. Finally, rescue experiments validated that miR-1307-3p was able to regulate CRC cell behaviors via regulating TUSC5 expression. Together, the current results indicate that miR-1307-3p functions as an oncogenic miRNA via targeting TUSC5 in CRC.
本研究的目的是探讨微小RNA-1307-3p(miR-1307-3p)在结直肠癌(CRC)中的作用。首先,使用逆转录定量聚合酶链反应检测CRC细胞中miR-1307-3p的表达水平。随后,分别进行细胞计数试剂盒-8和Transwell侵袭试验,以评估miR-1307-3p对CRC细胞增殖和侵袭的影响。使用生物信息学工具和双荧光素酶报告基因检测来验证miR-1307-3p的靶标。进行挽救实验以确认肿瘤抑制候选基因5(TUSC5)是miR-1307-3p的功能靶标。与正常人上皮细胞系相比,CRC细胞中miR-1307-3p水平上调。敲低miR-1307-3p可抑制CRC细胞的生长和侵袭性。生物信息学分析和双荧光素酶活性报告基因检测表明,miR-1307-3p与TUSC5的3'-非翻译区结合。最后,挽救实验证实miR-1307-3p能够通过调节TUSC5的表达来调节CRC细胞行为。总之,目前的结果表明,miR-1307-3p在CRC中通过靶向TUSC5发挥致癌性微小RNA的作用。